Panobinostat
Category: CancerPanobinostat Overview
Panobinostat (trade name Farydak /frdæk/ FAIR--dak) is a drug by Novartis for the treatment of various cancers. It is a hydroxamic acid[2] and acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor).[3] On 23 February 2015 it received FDA accelerated approval for use in patients with multiple myeloma,[4][5] and on 28 August 2015 it was approved by the European Medicines Agency for the same use.[6&a...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Panobinostat
Recent Panobinostat Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Panobinostat
- Capsule: 10mg, 15mg, 20mg
Other drugs which contain Panobinostat or a similar ingredient: (1 result)
- FARYDAK Panobinostat